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Methodsto Assess Respiratory Effects of
Complex Mixtures
by Michael D. Lebowitz*
Thispaperevaluatestheinfluenceofexposuresonacuteandchronicafrwayobstruction. Clinical, physiological, and
immunologicalaspectsareImportatine uatingthe fectsofthepo_utantexposures. Aspectsoftheexpos-response
relationshipsInportantenoughtorecordarethosefactorsinteractivewiththepollutants(eg.,smokingandotherper-
sonal/behaviodl factors)andp condirons. lbdetermin baseliestatusandstudychroniceffects,oneusesstan-
dardizedandmodifiedhealth and rd d p nary ct. Confirmatorystudiesofresponsive
airways, assessedfirstbydiurnalpeakflow, canbedoneusingpost-bronchodilatormaxlmumePIratory flow
volume curves and methacholinechallenge. Immunoglobuln determinations forImmunoogicl status (a predispos-
ilg/susceptbil f r), alle skintests(forimediate tivity status),andbloodoaums(mostyfore oils)
arealsoimpt.OtherteststhatcouldbePerforeincu expiredcarbon ndeand/orcauoyhemoglobin and
metm_oglobin(forsmokingandcombustioexposues).Meuresofacuteeffectsaresymptomaticresponses(byques-
tionairesanddiaries), responsesoftheairways (asmeasured by spirometry and peakflows), andchangesinmedica-




useofdifficultand costlyepidemiological and exposure assess-
menttechniquestoevaluateinteractions amongpollutantsinpro-
ducing measurable health responses (1-4). This is a difficult
task, asthewidevarietyofcontminantshavevaryingtemporal-
spatial concentrations, butit is necessary becausethecontribu-
tionsfromtheindoorenvironment arethought tobemajor(e.g.,
fromcombustionproducts, volatileorganiccompounds [VOCs]




onhealth. Estimates ofcontributing factors, theirindependent
andcollineardistributions, andthenumberofpeopleexposedto
different combinations ofthese factors are required, even for
selecting thestudypopulations. Theexpectedtimeinterval be-
tweenexposure(s) andtheeventual health effect mustbetaken
into account. Further, patterns ofresponse (5) andtheinterac-
tionbetweenpollutants andotherfactors such as socioeconomic
characeristicsofthehome, smoking, andoccupational exposure
can only be shown in population studies (2-4). Designs and
methods for such exposure-response studies are necessary,
especially newerand more cost-effective techniques.
Theoldapproachofevaluatingtherelationshipofasinglefac-
torto asingleeffect(one-at-a-timeapproach) haslimitationsin
both experimental and observational epidemiological studies.
*Environmental Programs, Division ofRespiratory Sciences, University of
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Theabilitytorelateexperimentalresultstononcontrolledsitua-
tions(whereallothervariablesarenotconstant)hasbeenlimited
by an overly simple design that excludes important covariates




responses when these are related to several factors (1,4,6).
Multifactorial experimental designs can permit more realistic
evaluationsoftherelationshipsbetweenvariables. Becauseofthe
specialcharacteristics oftheexposure-response relationships,
such studies will requiredesigns different from thoseoftradi-




person-days of observation for multivariate or time-series
analyses. However, effective specification ofstudy objectives
shouldimplywhatcombinationsofexposuresareofinterestand
reducetheneedforcompletely blockeddesigns (looking atall
possible combinations). By focusing the exposure/health
assessments onsubpopulations wheretherearelikely tobeex-
posures or responses of interest, the number of cases can be
reduced. Then the study design must provide precise meas-
urements of the exposure as well as health effects. This is
necessary to identify the effects of the contaminants, as dis-
finguishedfromanyotherfactorsrelatedtohealth. Existingcom-
binations of exposures are chosen for detailed evaluations of
plausiblecausalrelationshipswhilecontrollingforconfounding
factors. Becausetotalhumanexposuretoairpollutantsoccurin
a variety of environments, with contributions from several
sourcesandwithmixturesofpollutants,theproblemofuniquelyM. D. LEBOW17Z
identifying cause-effect relationships for a single pollutant is
complex.
Further, theselecting methodstoassess specifichealtheffects
is dependenton the characteristics ofexposures and ofthe an-
ticipated responses. These methods (andtheirquality control)
have been widely discussed (4-7). Themethods includeques-
tionnaire surveys, testsofphysiological function, bioassays, and
biological monitoring. Also, applications ofclinical and psy-
chophysicalmethods instudiesofindoorpollutantshaveproved




dized health questionnaires and baseline pulmonary function
measurements. Foracutechangesthatcanberecorded, oneuses
dailydiaries(symptoms, medications, doctorvisits, generaltime
allocation); diaries were developed clinically, then epi-
demiologicallyoverthepastfewdecades(6,9-12). Forobjective




samples are taken forCO, NO, and ET%. Serum, which canbe
frozen, isusedforbiochemicalandimmunochemicaldetermina-
tions. Such evaluations help to classify subjects for distinct
studies. Although used occupationally and clinically, radio-
graphs, especially forairwayobstructivediseases(AOD), have
notproved tobeespecially useful incommunitypopulations in
general or instudying effects ofcomplex mixtures indoors.
Questionnaires
Themostcommonly usedtool forderiving health indicators
ofchronic disease is the questionnaire. The questionnaire in-
cludesdemographicinformation, anthropomorphicinformation,
andinformationonacuteandchronicdiseasehistory. Italsooften
includes information onfaimily history, occupational exposure
histories, andresidentialhistories. Ageandsexarethemostim-
portantcovariables. Height, race, andweightarecriticalforuse
withfunctionstudies. Marital status, socioeconomicstatus, and
other demographic variables may be important intervening or
risk variables.
Thechest-allergyhistoryquestionsshouldincludequestions
on productive cough, wheeze, exertional dyspnea, attacks of
wheezingdyspnea, angina, historyofacuterespiratoryillnesses,
historyofchildhoodillnesses, presenceandphysicianconfirma-
tion ofcardiovascular restrictive lung and airway obstructive
diseases (emphysema, chronicbronchitis, bronchiectasis, asth-









naire is the British Medical Research Council questionnaire,
whichhasundergonerevisionssincearound 1954(13-15). The
pneumoconiosis unitoftheMedical ResearchCouncil (MRC)
alsohasitsownquestionnaire, whichcomparesfavorablytothe





stitute (NHLI), created a standard respiratory questionnaire
predominantlybasedontheMRCquestionnaire(20),whichhas
beenusedwidelyinstudiesofchronicrespiratorydiseaseinthe

















survey research centers and by the committee thatdevised the
previously described stndardized questionnaires. Randomness














volumein 1 sec(FEVI), andflowrates. Whenonederivesafull
flow-volumecurveorloop, onecanmeasuretheflowsat50and
75% ofexpired vital capacity. These are somewhat more sen-
sitivemeasuresoffunctionandchangesinfunctionandarethus
usefuladditions tothestandardspirometricmeasures (22,24).
The criteria for these tests have been described in detail
(22,25). These use consistent (reliable) methods. All the in-
strumentsrequireextensivetestingandcalibration. Theyallre-
quire excellent, well-trained technicians, appropriate instruc-
tions tothesubject, andcareful evaluationofthetests. Present
guidelinesrequirethatatleastthreegoodtestsbeperformedand
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NlakExpiratory FlowRate
Oneconditionthatinfluences pulmonary functiontemporal-
ly isbronchial responsiveness, considered to be akey risk fac-
torinthedevelopmentofAOD (27-31). Short-termchanges out-
sideofthelaboratory can userelatedmeasurements such asthe
peakexpiratory flow rate(PEFR); thePEFR canbeobtainedin
absolute terms fromtheFVC maneuver as well (9,22,32,33). It
is recommendedthatthePEFRfromtheFVC maneuverbeused
forquality assurance, but not as anabsolute measureoffunction
(22,34).
Itis recommendedthatthePEFRbeused as aninstrument to
measure relativechanges inbronchi (35-51), known asbronchial
responsiveness orlability, because thereliability andvalidity of
the PEFR for such usage has been shown by various studies
(35-51). With such usage, one candeterminehowmuch acute or
chronic change is required to be certain that improvement or
deteriorationhasoccurred, and one can comparethattonormal
changes (32,33,35,39,41,43,44,46). For such purposes, one can
usediurnal (within aday) orday-to-day variability/variation. For
instance, thenormal (95thpercentileof)diurnal variability is 16
to 20% in adults and 28% in children (52), the normal daily
variability in PEFR is ± 12% inadults in the laboratory and in
the field (44,52) and ± 20% in children (52). The daily varia-
tion ofPEFR in adults is similar to thatoftheir mid-flow rates
(44). The PEFR from the mini-Wright departs more from ab-
solute PEFR at very low and high flow rates (53,54).
The mini-Wright peak flow meter is a simple andinexpensive
device thathas proved useful in many studies, especially ofpa-
tients with reactiveairwaydiseases, andpreliminary studieshave
indicated its reliability and validity (40,42-44,55). Analysis of
day-to-day variation inpeakexpiratory flow rates havebeenused
tohelpdetermine the short-term effects ofenvironmental factors
on respiratory function (9,29,32,35,39,43-45,50,56,57).
TheATSandACCP(American CollegeofChestPhysicians)
have stated that an increased responsiveness ofthe airways to
various stimuli manifest byslowed forcedexpiration thatchanges
in severity either spontaneously or with treatnent is a char-
acteristic ofasthma. Thedefinition includes reference to bron-
chial reactivity though linked toairwaychanges; airway response
occurs inpatients with asthma and withrhinitis as well and can
occurinthosewith "bronchitic" (mucous hypersecretion) syn-
dromes (58; C. J. Holberg, personal communication). It occurs
in some percentageofnormal subjects aswell (27-29,32,33,37,
39,43,45,46,51,56,57,59,61). There is a fair amountofevidence
that bronchial responsiveness (or lability) is greatest in early
childhoodanddecreasesthereafter (32,33,S7,62). Davies etal.
(43) have argued that the PEFR may be of similar value to
histamine/methacholine provocation tests to distinguish
asthmatics, based on a UK delineation of astuna as a disease
characterized by wide variations over short periods oftime in
resistance toairway flow (63). "Traditionally, thediagnosis has
rested on the demonstration of this phenomenon either by
measuring airflow obstruction (FEVI) before and after a bron-
chodilator or more recently recording PEFRs using a mini-
Wrightpeakflow meter 3 or4times aday" (40). Theadvantage
ofmeasuring PEFRextendsbeyondthediagnosisofastunaand
is anobjective assessment. This type oftesthas many advantages
overbronchial provocation testing: peak flows are recorded by
the patient or subject, and the test is entirely safe; peak
flowscanbemeasuredirrespectiveoftheseverityoftheairflow
obstruction.
Example. Because most air pollutants are inhaled and have
theirmajorimfpactthroughthatrouteofentry,wehaveempirical-
lydetermineddifferentialresponsestoairpollutantexposuresin
the general population. We have worked on a framework for
usingintraindividual variability inpopulationsubgroups. This
approach is used to define criteria for responsiveness and for
predictingresponsestoindoorandoutdoor(i.e., totalexposure
to)pollutants, aero-allergens, weather, andinteractionsofthese
environmental factors. The use of peak flow rates or other
measuresofpulmnaryfiuctiontodetectabnormalityorsignifi-
cant change must incorporate the normal range ofbiological
variability and the normal degree ofintrasubject variability in
eachtest(32-34). Criteriaforsignificantintaindividualchanges
used healthy subjects ("normal" reference population). They
were identified as follows: a) absence ofreported respiratory
symptoms (diaryandhealthquestionnaire); b)absenceofsmok-
inghistory, currentorpast; andc)absenceofacuterespiratory
illnesssymptoms, including sorethroat,cough, wheezing, orat-
tacks ofshortness ofbreath with wheezing.
Diurnalchanges inPEFRwereevaluatedusingtheratioofthe
maximumofthenoonPEFR(N)orevening PEFR(E)withthe
minimum ofmorning (M) orbed PEFR(B)andtheamplitude
(maxinum-minimum) asapercentageoftheday'smeanPEFR.
The95thpercentiles inthedistributions inthese scoresandin-
dividualmeanswereusedtoidentifycriteriatoscreeneachday's
scores for excessive changes and to classify the overall study
population forsubsequenttesting. Theamplitude/mean wasless
than 30% for95% of 1201 person-days inthe5- to 15-year-old
group. The corresponding max (N,E)/min (M,B) ratio was
128%. Thesewereabouttwicethelimitsofthe 15to35agegroup
(amp/mean, 16.9%; max/min, 115.6%), although the 35 to 65
year olds were intermediate (amp/mean, 21.2%; max/min,
119.8%). Individuals havingmorethan5% oftheirtestdaysex-
ceedingeitheroftheselimits wereclassified ashavingexcessive
diurnal variation. Morethan30% ofthesubjectsexceededthese
limits; thisclassification wasabletodetectabout60% ofthecur-
rentdiagnoses asthmatics, withaspecificity near70%. Thesen-
sitivity washighestfortheyoungestagegroup(75%)andlowest




symptoms (62.2/53.1%, p < 0.05), acute respiratory illness
symptoms(48.5/36.1%,p < 0.01), also, specifically, coughand
sorethroat, wheezing orwhisding inthechest(16.6/7.29% = 2.3,
p < 0.001), andshortnessofbreathwithwheezing(11.2/4.09% =
2.8,p < 0.001). The ratio forchestcolds was 1.8 (p < 0.01), as
expected frompreviouswork. However, thesemoresusceptible
subjects didnotreport moreofthenonspecific symptoms (e.g.,
headache, dizziness, nausea), indicating specificity of the
criteria.
Other Pulmonary Function Tests
The other highly recommended test in studies ofrestrictive
lung diseases is the carbon monoxide diffusing capacity. It has
beenextensively reviewedanddescribed(22). Itisadifficulttest
toperform infieldconditions. Ithas alargedegreeofvariability
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and is the most semiquantitive in nature. However, there are
standardmethodsofperformingthetest(22). Thereisevidence
that in some patients with interstitial lung disease, the disease
manifestsitselffirstandprimarilybyrestrictionandreducedFVC,
whereasinotherpersonsitisthediffusingcapacitythatbecomes





properties, studies of pressure-volume curves using plethys-
mography are of great physiological value. However, they are
extremelydifficulttodoinfieldsettingsand arebothtime con-
suminganduncomfortable. Plethysmographycanalsobeusedto
obtain the total lung capacity and residual volume ofthe lung,
whoseratiovarieswithbothobstructiveandrestrictivedisease.
Available standard methods and their usefulness have been
describedindetailelsewhere(22).Othermethods,suchashelium
dilution and nitrogen washouttechniques, are also available to
determine these values, but are not as accurate. None ofthe
methods for obtaining accurate total lung capacity or residual
volumesarereadilyavailableforfieldstudies,andtheyrequireex-
tensiveknowledgeandequipment. Measuresofairwayresistance
arealsouseful testsin alaboratory setting. Theypresent agreat
deal ofdifficulty andvariability andhave notbeenshown tobe
critical resultindicatorsofchronicrespiratorydisease(22).
OtherTests
Carboxyhemoglobin measures are important in many con-
ditions in which carbon monoxide exposure is pertinent, as is





tests (e.g., complement, lymphocyte stimulation) also appear
promising.
Geneticpredisposingfactorstochronicrespiratorydiseasesare
veryimportant. However, nospecificgeneticfactorshavebeen so
clearlyindicatedastobevaluableinscreeningstudies.Theroles




and DNAantibodies (66), play aroleinrespiratory diseasebut
cannot be used epidemiologically. Bronchoalveoar lavage and
mucociliaryclearancestudieshavebeenshowntobeimportantin
general, butnotashealthoutcomes. Collagen, elastin, and sur-
factantarehighlycriticalinthefunctioningandthestructureofthe
lungs,butarealsoimpracticalanduncertainashealthindicators.
Many clinical techniques and other biochemical studies and
studiesoflungdefensemechanismsarelikelytobedevelopedfur-
therand may provesomeday tobehighlyuseful.
Discussion
More complex study designs, involving stratified or nested
sampling, require the use of appropriate analytic procedures





association, not to the determinationofcausation. Other con-
siderations include (67) the consistency of the relationship








impliedby itwith "generally knownfactsofthenaturalhistory
andbiologyofthedisease" (e.g., toxicological orexperimental
studies); andtheexperimental orsemi-experimentalmodifica-
tion ofexposure affects the frequencyofresponses.
Inpopulation-based studiesaconsiderableamountofeffortis
directed at characterizing, selecting, and recruiting a suitable
study population. This includes the initial identification and
screeningofthetotalpopulation, samplingtoobtainthestratified
cluster allocations for the study population, and various fol-
lowups (e.g., onnonrespondents forcharacterization). Thein-
itialscreeningincludesobtainingestimatesofconcentrationsof
differentcontaminantsinthedifferentexposuresettings. Apply-
ing the direct exposure- and health-assessment program to the
selected population groups involves additional efforts to enlist
their supportforthedurationofthe study (4). Theseactivities
are common for both single pollutant and complex mixture
studies. Themajordifference isinwhatinformationiscollected
by thedirectassessments: howefficiently does the study make
useofitsstudypopulation; whatquestionswillthestudybeable
to answer effectively because it contains adequate numbers of
subjectswhoareexposedandnonexposedtobothparticularand
mixtures ofcontaminants. Analytic adjustments will notcom-
pensateforinadequatedesigns. Theadditionaleffortneededto
collect several types of samples when already making the





controlofother, possiblyconfounding, factors inthedesignby
selectingsubpopulations and/orbyhavingmeasurementsofthe
otherfactors forindirect (covariance) adjustments. Whendeter-
mingwhatfactorstomeasureandselectingtechniques, resear-
chersshouldconsiderthedemands(timeandeffbrt)andinconve-
niences (e.g., noiseandappearanceofmonitors) placedonthe
study subjects relative tothebenefits (directandindirect) they
willreceive.Againstthe mptationtoaddmorequestionnairesor
monitorsistheriskofoverwhelmingthesubjectsandlosingtheir
support. (One benefit ofoffering both monitoring and health
evaluationstosubjectsisthattheyreceivemedicalanddiagnostic
testresultsthat areofinteresttothesubjects.) In some studies,
whereclinicvisitswerenecessitatedandwherebloodhasbeenre-
quired, refusal rates went above 50% (69). In well-motivated
populations,inwhichneitherbloodnorotherpainfultechniques
arerequired,refusalratesaregenerallylessthan25% (21). Sur-
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veysusingvanscannotusehighlysensitiveinstruments. Ifproper-
lymanaged, refusal rateswillrunbetween20and40% (70).
Field studies require the most hardy equipment. Whether
studies are performed in the home, motels, orplaces ofwork,
field studies usually rely onthe simplest and mosthardy spir-
ometrictechniquesandonquestionnaires. Occasionally, blood
samplescanbedrawnandskintestingcanbeperformed. Inad-
dition, a few ancillary techniques, such as blood pressure
measurements, can be obtained. Ifappropriately performed,
field studies should havethe lowest refusal ratebecausethe in-
vestigatorisconductingthemeasurementsintheusualplaceof
residence or work of the subject. Although many other
techniques appearpromising ashealth indicators, only a small
battery of tests are currently available. Thus, techniques that
should be required of all studies are questionnaires and
spirometric studies ofpulmonary function.
This workwassupportedbyEPACooperativeAgreementno. CR811806and
EPRIcontractno. RP2822. Althoughtheresearchdescribed inthisarticlehas
beenfundedwhollyorinpartbytheU.S. Environmental ProtectionAgency, it
has not been subjected to the Agency's required peer and policy review and
thereforedoesnotnecessarilv reflecttheviewsoftheAgency, andnoofficialen-
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